enVVeno Medical (NVNO) Profit After Tax (2017 - 2026)

enVVeno Medical's Profit After Tax history runs 10 years deep, the most recent figure standing at -$3.8 million for Q1 2026.

• In Q1 2026, Profit After Tax rose 14.52% year-over-year to -$3.8 million; the TTM figure through Mar 2026 stood at -$18.8 million (up 11.78% YoY), while the FY2025 annual figure was -$19.5 million, up 10.76% from the prior year.
• Profit After Tax was -$3.8 million for Q1 2026 at enVVeno Medical, down from -$3.7 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of -$3.7 million in Q4 2025 to a low of -$7.1 million in Q2 2022.
• Historically, Profit After Tax has averaged -$5.5 million across 5 years, with a median of -$5.6 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Profit After Tax sank 196.97% in 2022, then jumped 40.02% in 2025.
• A 5-year view of Profit After Tax shows it stood at -$6.2 million in 2022, then climbed by 8.59% to -$5.6 million in 2023, then retreated by 10.27% to -$6.2 million in 2024, then soared by 40.02% to -$3.7 million in 2025, then declined by 3.02% to -$3.8 million in 2026.
• The last three Profit After Tax figures came in at -$3.8 million (Q1 2026), -$3.7 million (Q4 2025), and -$4.5 million (Q3 2025), per Business Quant data.